8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE
- CAS No.
- 691868-88-9
- Chemical Name:
- 8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE
- Synonyms
- RO8191;CDM-3008;RO4948191;2-[2,4-Bis(trifluoromethyl)imidazo[1,2-a]1,8-naphthyridin-8-yl]-1,3,4-oxadiazole;8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE;Imidazo[1,2-a][1,8]naphthyridine, 8-(1,3,4-oxadiazol-2-yl)-2,4-bis(trifluoromethyl)-;HCV,Inhibitor,JAK,Hepatitis C virus,Interferon-alpha/beta receptor,CDM3008,Janus kinase,EMCV,CDM 3008,Tyk2,RO-4948191,RO 4948191,HBV,RO8191,interferon,orally,IFNAR,ISGs,cccDNA,IFNAR1,STAT,inhibit,JAK1,RO-8191,RO 8191,Hepatitis B virus,IFNAR2,imidazonaphthyridine,Interferon-α/β receptor,replicon
- CBNumber:
- CB2134747
- Molecular Formula:
- C14H5F6N5O
- Molecular Weight:
- 373.21
- MOL File:
- Mol file
- Modify Date:
- 2024/7/2 8:55:02
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS06 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Danger | |||||||||
Hazard statements | H301 | |||||||||
Precautionary statements | P264-P270-P301+P310-P321-P330-P405-P501 | |||||||||
NFPA 704 |
|
8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE Preparation Products And Raw materials
Raw materials
Preparation Products
8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE Suppliers
Global( 33)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | United States | 19892 | 58 | Inquiry |
Suzhou ARTK Medchem Co., Ltd. | +86-512-68323658 +86-18168183658 | China | 39010 | 58 | Inquiry |
InvivoChem | 13549236410 | China | 6755 | 58 | Inquiry |
Henan Alpha Chemical Co., Ltd. | 0371-55013243 15324716602 | China | 10010 | 58 | Inquiry |
Guangzhou Younan Technology Co., Ltd | 020-020-82000279 18988968278 | China | 4297 | 58 | Inquiry |
Bide Pharmatech Ltd. | 400-1647117 13681763483 | China | 62163 | 58 | Inquiry |
Shanghai EFE Biological Technology Co., Ltd. | 021-65675885 18964387627 | China | 9806 | 58 | Inquiry |
TargetMol Chemicals Inc. | 4008200310 | China | 24647 | 58 | Inquiry |
Nanjing Tengyi Biotechnology Co., Ltd | 025-58851786 17714337195 | China | 7417 | 58 | Inquiry |
Cayman Chemical Company | (800) 364-9897 | United States | 6618 | 81 | Inquiry |
8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE
RO8191
Imidazo[1,2-a][1,8]naphthyridine, 8-(1,3,4-oxadiazol-2-yl)-2,4-bis(trifluoromethyl)-
2-[2,4-Bis(trifluoromethyl)imidazo[1,2-a]1,8-naphthyridin-8-yl]-1,3,4-oxadiazole
CDM-3008
RO4948191
HCV,Inhibitor,JAK,Hepatitis C virus,Interferon-alpha/beta receptor,CDM3008,Janus kinase,EMCV,CDM 3008,Tyk2,RO-4948191,RO 4948191,HBV,RO8191,interferon,orally,IFNAR,ISGs,cccDNA,IFNAR1,STAT,inhibit,JAK1,RO-8191,RO 8191,Hepatitis B virus,IFNAR2,imidazonaphthyridine,Interferon-α/β receptor,replicon
691868-88-9
C14H5F6N5O